
Yunnan
300957.SZYunnan Botanee Bio-Technology Group Co.LTD Price (300957.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
422,790,507
(0.1911)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Yunnan Botanee Bio-Technology Group Co.LTDCurrency: CNY
YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
798,044,165.00
+0% |
1,240,490,198.00
+55% |
1,943,745,540.00
+57% |
2,636,488,348.00
+36% |
4,022,403,431.00
+53% |
5,013,873,729.00
+25% |
5,522,168,263.00
+10% |
||||||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 149,421,863.00 | 233,742,487.00 | 384,514,380.00 | 626,059,725.00 | 965,167,028.00 | 1,243,046,954.00 | 1,441,392,430.00 | ||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
648,622,302.00
+0% |
1,006,747,711.00
+55% |
1,559,231,160.00
+55% |
2,010,428,623.00
+29% |
3,057,236,403.00
+52% |
3,770,826,775.00
+23% |
4,080,775,833.00
+8% |
||||||||||||
Gross Profit Ratio | (0.81%) | (0.81%) | (0.80%) | (0.76%) | (0.76%) | (0.75%) | (0.74%) | ||||||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 28,917,493.00 | 46,012,695.00 | 54,109,130.00 | 63,441,047.00 | 113,221,150.00 | 254,698,441.00 | 298,817,308.00 | ||||||||||||
General and Administrative | -223,507,239.51 | -320,655,227.45 | -295,528,509.24 | -40,882,843.18 | 120,812,336.00 | 152,651,532.00 | 176,582,620.00 | ||||||||||||
Selling, General & Admin... | 104,393,508.00 | 181,977,691.00 | 547,826,038.00 | 1,066,249,232.00 | 1,801,581,882.00 | 2,200,532,287.00 | 3,035,852,607.00 | ||||||||||||
Selling & Marketing Exp... | 327,900,747.00 | 502,632,919.00 | 843,354,547.00 | 1,107,132,076.00 | 1,680,769,545.00 | 2,047,880,755.00 | 2,191,935,222.00 | ||||||||||||
Depreciation and Amortiz... | 10,018,800.00 | 12,569,200.00 | 20,596,427.00 | 24,881,685.00 | 73,394,789.00 | 91,929,476.00 | 137,892,861.00 | ||||||||||||
Other Expenses | 7,767,890.00 | -3,633,993.68 | 443,016,401.00 | 220,293,296.00 | 149,756,433.00 | 174,613,531.00 | -152,064,909.00 | ||||||||||||
Total Operating Expenses | 457,295,581.00 | 685,899,941.00 | 1,044,951,570.00 | 1,349,983,577.00 | 2,064,559,466.00 | 2,629,844,259.00 | 3,202,802,136.00 | ||||||||||||
Cost and Exponses | 606,717,444.00 | 919,642,428.00 | 1,429,465,950.00 | 1,976,043,302.00 | 3,029,726,494.00 | 3,872,891,214.00 | 4,644,194,567.00 | ||||||||||||
Operating Income | |||||||||||||||||||
Operating Income |
186,087,353.00
+0% |
312,672,910.00
+68% |
502,076,919.00
+61% |
649,701,211.00
+29% |
1,015,709,779.00
+56% |
1,212,109,056.00
+19% |
877,973,695.00
-28% |
||||||||||||
Operating Income Ratio | (0.23%) | (0.25%) | (0.26%) | (0.25%) | (0.25%) | (0.24%) | (0.16%) | ||||||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 3,955,747.00 | 6,207,517.00 | 8,163,777.00 | 5,132,106.00 | 14,793,775.00 | 20,299,817.00 | 28,548,283.00 | ||||||||||||
Interest Expenses | 12,214,699.00 | 202,851.00 | 132,721.00 | 2,669,226.00 | 4,187,444.00 | 4,753,216.00 | 4,966,901.00 | ||||||||||||
Total Other Income/Exp... | 329,390.00 | 516,470.00 | 164,816.00 | -1,862,410.00 | 2,166,292.00 | 1,755,570.00 | -9,155,146.00 | ||||||||||||
EBITDA | |||||||||||||||||||
EBITDA | 199,085,646.00 | 325,961,478.00 | 515,538,069.00 | 663,715,893.00 | 1,095,458,304.00 | 1,309,188,565.00 | 1,011,678,311.00 | ||||||||||||
EBITDA ratio | (0.29%) | (0.30%) | (0.30%) | (0.26%) | (0.27%) | (0.27%) | (0.18%) | ||||||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 186,416,743.00 | 313,189,380.00 | 502,241,735.00 | 647,838,801.00 | 1,017,876,071.00 | 1,213,864,625.00 | 868,818,549.00 | ||||||||||||
Income Before Tax Ratio | (0.23%) | (0.25%) | (0.26%) | (0.25%) | (0.25%) | (0.24%) | (0.16%) | ||||||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 31,011,120.00 | 50,266,520.00 | 89,180,429.00 | 104,084,057.00 | 153,813,617.00 | 163,448,256.00 | 109,606,792.00 | ||||||||||||
Net Income | |||||||||||||||||||
Net Income | 153,630,833.00
+0% |
260,526,567.00
+70% |
411,945,198.00
+58% |
543,507,903.00
+32% |
862,922,946.00
+59% |
1,051,331,949.00
+22% |
756,795,007.00
-28% |
||||||||||||
Net Income Ratio | (0.19%) | (0.21%) | (0.21%) | (0.21%) | (0.21%) | (0.21%) | (0.14%) | ||||||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 0.43 | 0.72 | 0.97 | 1.28 | 2.04 | 2.48 | 1.79 | ||||||||||||
Diluted EPS | 0.43 | 0.72 | 0.97 | 1.28 | 2.04 | 2.48 | 1.79 | ||||||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 361,355,437.00 | 361,355,437.00 | 423,600,000.00 | 423,600,000.00 | 423,600,000.00 | 423,600,000.00 | 422,790,507.00 | ||||||||||||
Diluted Share Outstanding | 361,355,437.00 | 361,355,437.00 | 423,600,000.00 | 423,600,000.00 | 423,600,000.00 | 423,600,000.00 | 422,790,507.00 |